Empagliflozin in Heart Failure with a Preserved Ejection Fraction

N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Glucosides* / therapeutic use
  • Heart Failure* / drug therapy
  • Humans
  • Stroke Volume

Substances

  • Benzhydryl Compounds
  • Glucosides
  • empagliflozin